A Pooled Analysis of the Cardiac Events in the Trastuzumab Adjuvant Trials

por de Azambuja, Evandro, Ponde, Noam, Procter, Marion, Rastogi, Priya, Cecchini, Reena, Lambertini, Matteo, Ballman, Karla, Aspitia, Alvaro Moreno, Zardavas, Dimitrios, Roca, Lise, Gelber, Richard D., Piccart-Gebhart, Martine, Suter, Thomas
Publicado en Breast Cancer Res Treat (2019)

Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience

por Metzger-Filho, Otto, de Azambuja, Evandro, Procter, Marion, Krieguer, Magalie, Smith, Ian, Baselga, Jose, Cameron, David, Untch, Michael, Jackisch, Christian, Bell, Richard, Gianni, Luca, Goldhirsch, Aron, Piccart, Martine, Gelber, Richard D.
Publicado en Breast Cancer Res Treat (2015)

Disease-Free Survival According to Degree of HER2 Amplification for Patients Treated With Adjuvant Chemotherapy With or Without 1 Year of Trastuzumab: The HERA Trial

por Dowsett, Mitch, Procter, Marion, McCaskill-Stevens, Worta, de Azambuja, Evandro, Dafni, Urania, Rueschoff, Josef, Jordan, Bruce, Dolci, Stella, Abramovitz, Mark, Stoss, Oliver, Viale, Giuseppe, Gelber, Richard D., Piccart-Gebhart, Martine, Leyland-Jones, Brian
Publicado 2009

Patient-reported function, health-related quality of life, and symptoms in APHINITY: pertuzumab plus trastuzumab and chemotherapy in HER2-positive early breast cancer

por Bines, José, Clark, Emma, Barton, Claire, Restuccia, Eleonora, Procter, Marion, Sonnenblick, Amir, Fumagalli, Debora, Parlier, Damien, Arahmani, Amal, Baselga, José, Viale, Giuseppe, Reaby, Linda L., Frank, Elizabeth, Gelber, Richard D., Piccart, Martine, Jackisch, Christian, Petersen, Jennifer A.
Publicado en Br J Cancer (2021)

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer

por von Minckwitz, Gunter, Procter, Marion, de Azambuja, Evandro, Zardavas, Dimitrios, Benyunes, Mark, Viale, Giuseppe, Suter, Thomas, Arahmani, Amal, Rouchet, Nathalie, Clark, Emma, Knott, Adam, Lang, Istvan, Levy, Christelle, Yardley, Denise A., Bines, Jose, Gelber, Richard D., Piccart, Martine, Baselga, Jose
Publicado en N Engl J Med (2017)

11 years’ follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

por Cameron, David, Piccart-Gebhart, Martine J, Gelber, Richard D, Procter, Marion, Goldhirsch, Aron, de Azambuja, Evandro, Castro, Gilberto, Untch, Michael, Smith, Ian, Gianni, Luca, Baselga, Jose, Al-Sakaff, Nedal, Lauer, Sabine, McFadden, Eleanor, Leyland-Jones, Brian, Bell, Richard, Dowsett, Mitch, Jackisch, Christian
Publicado en Lancet (2017)